Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder

被引:62
|
作者
Lee, Sang Hyuk
Ahn, Seung Chan
Lee, Yu Jin
Choi, Tae Kyu
Yook, Ki Hwan
Suh, Shin Young
机构
[1] Pochon CHA Univ, Coll Med, Dept Psychiat, Songnam, South Korea
[2] Korea Inst Brain Sci, Seoul, South Korea
关键词
anxiety disorder; stress management; meditation; MINDFULNESS MEDITATION; REDUCTION INTERVENTION; DEPRESSION; BEHAVIOR;
D O I
10.1016/j.jpsychores.2006.09.009
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The objective of this study was to examine the effectiveness of a meditation-based stress management program in patients with anxiety disorder. Methods: Patients with anxiety disorder were randomly assigned to an 8-week clinical trial of either a meditation-based stress management program or an anxiety disorder education program. The Hamilton Anxiety Rating Scale (HAM-A), the Hamilton Depression Rating Scale (HAM-D), the State-Trait Anxiety Inventory (STAI), the Beck Depression Inventory, and the Symptom Checklist-90-Revised (SCL-90-R) were used to measure outcome at 0, 2, 4, and 8 weeks of the program. Results: Compared to the education group, the meditation-based stress management group showed significant improvement in scores on all anxiety scales (HAM-A, P=.00; STAI state, P=.00; STAI trait, P=.00; anxiety subscale of SCL-90-R, P=.00) and in the SCL-90-R hostility subscale (P=.01). Findings on depression measures were inconsistent, with no significant improvement shown by subjects in the meditation-based stress management group compared to those in the education group. The meditation-based stress management group did not show significant improvement in somatization, obsessive-compulsive symptoms, and interpersonal sensitivity scores, or in the SCL-90-R phobic anxiety subscale compared to the education group, Conclusions: A meditation-based stress management program can be effective in relieving anxiety symptoms in patients with anxiety disorder. However, well-designed, randomized, and controlled trials are needed to scientifically prove the worth of this intervention prior to treatment. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:189 / 195
页数:7
相关论文
共 50 条
  • [31] Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine
    Stein, Dan J.
    NEUROLOGY AND THERAPY, 2023, 12 (SUPPL 1) : 13 - 19
  • [32] Effectiveness of self-training using the mobile-based virtual reality program in patients with social anxiety disorder
    Kim, Hesun Erin
    Hong, Yeon-Ju
    Kim, Min-Kyeong
    Jung, Young Hoon
    Kyeong, Sunghyon
    Kim, Jae-Jin
    COMPUTERS IN HUMAN BEHAVIOR, 2017, 73 : 614 - 619
  • [33] The use of quetiapine as an adjunct in the pharmacotherapy of generalised anxiety disorder: a flexible-dose, open-label trial
    Katzman, M.
    Vermani, M.
    Jacobs, L.
    Marcus, M.
    Kong, B. B.
    Lessard, S.
    Galarraga, W.
    Struzik, L.
    Iorio, C.
    Gendron, A.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 324 - 325
  • [34] The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder
    Hoge, Elizabeth A.
    Bui, Eric
    Palitz, Sophie A.
    Schwarz, Noah R.
    Owens, Maryann E.
    Johnston, Jennifer M.
    Pollack, Mark H.
    Simon, Naomi M.
    PSYCHIATRY RESEARCH, 2018, 262 : 328 - 332
  • [35] Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine
    Stein, Dan J.
    ADVANCES IN THERAPY, 2021, 38 (SUPPL 2) : 52 - 60
  • [36] A 2010 Evidence-Based Algorithm for the Pharmacotherapy of Social Anxiety Disorder
    Dan J. Stein
    David S. Baldwin
    Borwin Bandelow
    Carlos Blanco
    Leonardo F. Fontenelle
    Sing Lee
    Hisato Matsunaga
    David Osser
    Murray B. Stein
    Michael van Ameringen
    Current Psychiatry Reports, 2010, 12 : 471 - 477
  • [37] A 2010 Evidence-Based Algorithm for the Pharmacotherapy of Social Anxiety Disorder
    Stein, Dan J.
    Baldwin, David S.
    Bandelow, Borwin
    Blanco, Carlos
    Fontenelle, Leonardo F.
    Lee, Sing
    Matsunaga, Hisato
    Osser, David
    Stein, Murray B.
    van Ameringen, Michael
    CURRENT PSYCHIATRY REPORTS, 2010, 12 (05) : 471 - 477
  • [38] Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine
    Dan J. Stein
    Advances in Therapy, 2021, 38 : 52 - 60
  • [39] Meditation-based intervention for obsessive-compulsive disorder: A PRISMA-compliant systematic review and meta-analysis
    Lee, Si Myeong
    Suh, Hyo-Weon
    Kwak, Hui-Yong
    Kim, Jong Woo
    Chung, Sun-Yong
    MEDICINE, 2022, 101 (30) : E29147
  • [40] Effectiveness of Aripiprazole in Bipolar Disorder Patients Primarily Taking Complex Pharmacotherapy
    Ittasakul, Pichai
    Srivastava, Shefali
    Wang, Po W.
    Hill, Shelley J.
    Childers, Meredith E.
    Ketter, Terence A.
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 92S - 92S